Abstract:Background: Peritoneal dissemination is common in advanced ovarian cancer. The completeness of cytoreduction is an independent prognostic factor. The intraoperative fluorescence imaging via tumor-specific near-infrared fluorophore might improve staging and surgical completeness. A promising target for ovarian cancer is the gonadotropin-releasing hormone receptor (GnRHR). This study aimed to develop a GnRHR-targeted near-infrared imaging probe for the detection of peritoneal metastases of ovarian cancer. Methods: Indocyanine green (ICG) was conjugated with GnRH antagonist peptide to develop an ovarian cancer-selective fluorescence probe GnRHa-ICG. GnRHR expression was detected in ovarian cancer tissues. The binding capacity of GnRHa-ICG and ICG was detected in both cancer cell lines and mouse models of peritoneal metastatic ovarian cancer using fluorescence microscopy, flow cytometry, and near-infrared fluorescence imaging. Results: Tissue microarray analysis revealed the overexpression of GnRHR in ovarian cancer. GnRH-ICG exhibited the binding capacity in a panel of cancer cell lines with different expression levels of GnRHR. In ovarian cancer mouse models, GnRHa-ICG signals were detected in peritoneal tumor lesions rather than normal peritoneal and intestines tissues. ICG showed intensive fluorescence signals in intestines. The tumor-to-muscle ratio and tumor-to-intestine ratio of GnRHa-ICG was 7.41 ± 2.82 and 4.37 ± 1.66, higher than that of ICG (4.60 ± 0.50 and 0.57 ± 0.06) at 2 h post administration. The fluorescence signal of peritoneal metastases peaked in intensity at 2 h and maintained for up to 48 h. ICG also showed a weak signal in the tumor lesions due to the enhanced permeability and retention effect, but the intensity decreased quickly within 48 h. Conclusions: The developed GnRHR-targeted imaging agent GnRHa-ICG could specifically detected peritoneal tumor lesions from normal peritoneal and intestines tissues because of the modification of GnRHa to ICG. The plateau period of GnRHa-ICG accumulation may be feasible for clinical applications in fluorescence-guided surgery. Our GnRHR imaging concept may be effective in other hormone-related tumors with upregulated GnRHR expression.

Live Imaging Of Follicle Stimulating Hormone Receptors In Gonads And Bones Using Near Infrared Ii Fluorophore

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Long-term monitoring of intravital biological processes using fluorescent protein-assisted NIR-II imaging

A Follicle-Stimulating Hormone Receptor-Targeted Near-Infrared Fluorescent Probe for Tumor-Selective Imaging and Photothermal Therapy

Research of NIR-II small animal living fluorescence imaging system

Biocompatible Near-Infrared Fluorescent Nanoparticles for Macro and Microscopic in Vivo Functional Bioimaging.

Downshifting nanoprobes with follicle stimulating hormone peptide fabrication for highly efficient NIR II fluorescent bioimaging guided ovarian tumor surgery

Gonadotropin-Releasing Hormone Receptor-Targeted Near-Infrared Fluorescence Probe for Specific Recognition and Localization of Peritoneal Metastases of Ovarian Cancer.

3D NIR‐II Molecular Imaging Distinguishes Targeted Organs with High‐Performance NIR‐II Bioconjugates

Fluorescence-surface enhanced Raman scattering co-functionalized gold nanorods as near-infrared probes for purely optical in vivo imaging.

NIR-II Fluorescence Imaging for the Detection and Resection of Cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic Ovarian Cancer Models

PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging.

In Vivo Tumor Imaging in Mice with Near-Infrared: Low Density Lipoprotein Conjugates

Imaging Transgenic Nude Mice Expressing Spectrally-distinct Fluorescent Reporters Emitting From Blue to Far Red Light With One Instrument With Single-nanometer-tuning of Laser-excitation Fluorescence

In Vivo Imaging of Rabbit Follicles Through Combining Ultrasound Bio-Microscopy and Intravital Window

A high quantum yield molecule-protein complex fluorophore for near-infrared II imaging

In Vivo and in Situ Imaging of Head and Neck Squamous Cell Carcinoma Using Near-Infrared Fluorescent Quantum Dot Probes Conjugated with Epidermal Growth Factor Receptor Monoclonal Antibodies in Mice.

In Vivo Fluorescence Reflectance Imaging with Subcutaneous Mouse Tumor Models.

Advancing breast cancer diagnosis with a near-infrared fluorescence imaging smart sensor for estrogen/progesterone receptor detection

Application of near-infrared fluorescence molecular imaging in nude mice xenograft models of ovarian cancer

Molecular Imaging of Small Animals with Fluorescent Proteins: from Projection to Multimodality